IL272939A - Vinyl heterocycles as RHO-linked coiled-coil kinase inhibitors - Google Patents
Vinyl heterocycles as RHO-linked coiled-coil kinase inhibitorsInfo
- Publication number
- IL272939A IL272939A IL272939A IL27293920A IL272939A IL 272939 A IL272939 A IL 272939A IL 272939 A IL272939 A IL 272939A IL 27293920 A IL27293920 A IL 27293920A IL 272939 A IL272939 A IL 272939A
- Authority
- IL
- Israel
- Prior art keywords
- vinylheterocycles
- rho
- rock
- inhibitors
- associated coiled
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762553885P | 2017-09-03 | 2017-09-03 | |
| PCT/US2018/049225 WO2019046795A1 (en) | 2017-09-03 | 2018-08-31 | VINYL HETEROCYCLES AS INHIBITORS OF RHO (ROCK) ASSOCIATED BISPIRALIZED KINASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL272939A true IL272939A (en) | 2020-04-30 |
Family
ID=65526110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL272939A IL272939A (en) | 2017-09-03 | 2020-02-27 | Vinyl heterocycles as RHO-linked coiled-coil kinase inhibitors |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11542256B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3676262A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2020532551A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111406051A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018326785B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3073956A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL272939A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019046795A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11542256B2 (en) | 2017-09-03 | 2023-01-03 | Angion Biomedica Corp. | Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors |
| WO2021016256A2 (en) * | 2019-07-22 | 2021-01-28 | Angion Biomedica Corp. | Ethynylheterocycles as rho-associated coiled-coil kinase (rock) inhibitors |
| TW202132285A (zh) * | 2019-11-13 | 2021-09-01 | 美商愛彼特生物製藥股份有限公司 | 經取代異吲哚啉基2,2’-聯嘧啶基化合物、其類似物及使用其之方法 |
| CN116209658A (zh) * | 2020-07-21 | 2023-06-02 | 安吉昂生物医药公司 | Rho相关卷曲螺旋激酶的抑制剂 |
| JP2025515296A (ja) * | 2022-04-20 | 2025-05-14 | シャンハイ ジムン バイオファーマ,インコーポレーテッド | Rho関連プロテインキナーゼ阻害剤ならびにその調製および応用 |
| CN119998295A (zh) | 2022-06-08 | 2025-05-13 | 因赛特公司 | 作为dgk抑制剂的三环三唑并化合物 |
| US12600723B2 (en) | 2022-07-18 | 2026-04-14 | Incyte Corporation | Tetracyclic compounds as DGK inhibitors |
| US12600722B2 (en) | 2022-07-18 | 2026-04-14 | Incyte Corporation | Tetracyclic compounds as DGK inhibitors |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5322756A (en) | 1992-07-09 | 1994-06-21 | Xerox Corporation | Magnetic fluids and method of preparation |
| MY134008A (en) | 1999-12-22 | 2007-11-30 | Merck Frosst Canada Inc | Subtituted 8-arylquinoline phospohodiestrase-4 inhibitors |
| WO2002072578A2 (en) | 2001-03-08 | 2002-09-19 | Millennium Pharmaceuticals | (homo) piperazine substituted quinolines for inhibiting the phosphorylation of kinases |
| DE102004039280A1 (de) * | 2004-08-13 | 2006-02-23 | Merck Patent Gmbh | 1,5-Diphenyl-pyrazole |
| CR9465A (es) | 2005-03-25 | 2008-06-19 | Surface Logix Inc | Compuestos mejorados farmacocineticamente |
| CA2660560A1 (en) * | 2006-08-16 | 2008-02-21 | Boehringer Ingelheim International Gmbh | Pyrazine compounds, their use and methods of preparation |
| KR20090057032A (ko) | 2006-09-21 | 2009-06-03 | 노파르티스 아게 | 사이토카인 매개 질환의 치료에 유용한 피롤 유도체 |
| US7758972B2 (en) * | 2006-09-26 | 2010-07-20 | Semiconductor Energy Laboratory Co., Ltd. | Stilbene derivative, light emitting element, light emitting device, and electronic appliance |
| CA2700988A1 (en) | 2006-09-27 | 2008-05-08 | Surface Logix, Inc. | Rho kinase inhibitors |
| KR101455428B1 (ko) | 2007-02-28 | 2014-10-27 | 제이엔씨 석유 화학 주식회사 | Cf2o 결합기를 갖는 5 고리 액정 화합물, 액정 조성물 및 액정 표시 소자 |
| DE112008000841T5 (de) | 2007-03-29 | 2010-02-11 | Sumitomo Chemical Company, Limited | Verbindung, photoelektrischer Wandler und photoelektrochemische Zelle |
| MX2011009568A (es) | 2009-03-09 | 2011-12-06 | Surface Logix Inc | Inhibidores de la rho cinasa. |
| WO2011011312A1 (en) | 2009-07-22 | 2011-01-27 | Merck Sharp & Dohme Corp. | Quinolinone pde2 inhibitors |
| NZ602191A (en) | 2010-03-02 | 2014-07-25 | Amakem Nv | Heterocyclic amides as rock inhibitors |
| WO2012040499A2 (en) | 2010-09-22 | 2012-03-29 | Surface Logix, Inc. | Metabolic inhibitors |
| JP5809954B2 (ja) | 2011-12-15 | 2015-11-11 | 富士フイルム株式会社 | 光電変換素子及び色素増感太陽電池 |
| RS63503B1 (sr) | 2012-10-05 | 2022-09-30 | Kadmon Corporation Llc | Inhibitori rho kinaze |
| EP2961405A4 (en) | 2012-12-14 | 2017-03-29 | The Brigham and Women's Hospital, Inc. | Methods and assays relating to macrophage differentiation |
| HUE033962T2 (en) | 2013-01-29 | 2018-01-29 | Redx Pharma Plc | Pyridine derivatives as soft rock (RHO kinase) inhibitors |
| US11311541B2 (en) | 2014-04-09 | 2022-04-26 | Kadmon Corporation, Llc | Treatment of GVHD |
| JP6310558B2 (ja) | 2014-06-11 | 2018-05-16 | 富士フイルム株式会社 | 光電変換素子、色素増感太陽電池、金属錯体色素、色素溶液、およびターピリジン化合物またはそのエステル化物 |
| US9902702B2 (en) * | 2014-07-15 | 2018-02-27 | Bristol-Myers Squibb Company | Spirocycloheptanes as inhibitors of rock |
| US10011600B2 (en) | 2014-09-25 | 2018-07-03 | Araxes Pharma Llc | Methods and compositions for inhibition of Ras |
| WO2016081554A1 (en) | 2014-11-18 | 2016-05-26 | Neostem Oncology, Llc | Immunogenic compositions prepared from tumor cells derived from peripheral blood and originating from a solid tumor and their use |
| MX2017008844A (es) | 2015-01-09 | 2018-03-14 | Gilead Apollo Llc | Terapia de combinacion con inhibidor de acetil-coa carboxilasa (acc) para el tratamiento de enfermedad de higado graso no alcoholico. |
| US10106525B2 (en) | 2015-01-26 | 2018-10-23 | BioAxone BioSciences, Inc. | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof |
| US9687483B2 (en) | 2015-01-26 | 2017-06-27 | BioAxone BioSciences, Inc. | Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitors |
| US10149856B2 (en) | 2015-01-26 | 2018-12-11 | BioAxone BioSciences, Inc. | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors |
| ES2730112T3 (es) * | 2015-03-09 | 2019-11-08 | Bristol Myers Squibb Co | Lactamas como inhibidores de ROCK |
| JP2018522942A (ja) | 2015-05-29 | 2018-08-16 | エッジ セラピューティクス インコーポレイテッド | 視力障害を低減するための組成物及び方法 |
| WO2016204256A1 (ja) | 2015-06-16 | 2016-12-22 | 国立大学法人京都大学 | 高機能性血小板の製造方法 |
| SG11201808625QA (en) | 2016-04-04 | 2018-10-30 | Chemocentryx Inc | SOLUBLE C5aR ANTAGONISTS |
| JP2019112307A (ja) | 2016-04-28 | 2019-07-11 | 宇部興産株式会社 | 置換ジヒドロピロロピラゾール化合物および他の乾癬治療薬が組み合わせて投与される医薬組成物 |
| KR102444366B1 (ko) | 2016-06-03 | 2022-09-19 | 케모센트릭스, 인크. | 간 섬유화 치료 방법 |
| CN107019698A (zh) | 2016-08-04 | 2017-08-08 | 上海市第十人民医院 | Rock2抑制剂在制备炎症性肠病药物中的应用 |
| CA3036378A1 (en) | 2016-09-13 | 2018-03-22 | President And Fellows Of Harvard College | Methods relating to intestinal organ-on-a-chip |
| KR101892154B1 (ko) | 2017-02-22 | 2018-08-28 | 한국과학기술연구원 | Rho-연관된 단백질 키나제 저해제를 포함하는 면역 반응 증강용 조성물 및 이를 이용한 방법 |
| CN106916145B (zh) | 2017-03-06 | 2019-06-04 | 上海应用技术大学 | SLx-2119的合成方法 |
| SG11201907673YA (en) | 2017-03-13 | 2019-09-27 | Genfit | Pharmaceutical compositions for combination therapy |
| CN110573148A (zh) | 2017-03-16 | 2019-12-13 | 武田有限公司 | 特发性肺纤维化的治疗 |
| CA3058542A1 (en) | 2017-04-18 | 2018-10-25 | Genfit | Combination comprising a ppar agonist such as elafibranor and an acetyl-coa carboxylase (acc) inhibitor |
| ES2982341T3 (es) | 2017-06-30 | 2024-10-15 | Quixgen Inc | Nuevos compuestos de espirolactona |
| US11542256B2 (en) | 2017-09-03 | 2023-01-03 | Angion Biomedica Corp. | Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors |
| GB201715928D0 (en) | 2017-09-30 | 2017-11-15 | Auckland Uniservices Ltd | Method |
| GB201715930D0 (en) | 2017-09-30 | 2017-11-15 | Upside Biotechnologies Ltd | Cell Culture Medium |
| CN111741754A (zh) | 2017-10-30 | 2020-10-02 | 凯莫森特里克斯股份有限公司 | 作为免疫调节剂的氘代化合物 |
| WO2019099457A1 (en) | 2017-11-14 | 2019-05-23 | Quixgen, Inc. | Benzodioxinone compounds |
| IL308604B2 (en) | 2017-12-06 | 2025-08-01 | Basf As | Fatty acid derivatives for treating non-alcoholic steatohepatitis |
| MX2020006459A (es) | 2017-12-22 | 2020-11-06 | Chemocentryx Inc | Compuestos de anillos fusionados 6,5 diaril sustituidos como inhibidores de c5ar. |
| MA51327A (fr) | 2017-12-22 | 2021-05-26 | Chemocentryx Inc | Composés cycliques fusionnés en 5,5 à substitution diaryle, utilisés en tant qu'inhibiteurs du c5ar |
| ES2993034T3 (en) | 2018-04-02 | 2024-12-20 | Chemocentryx Inc | Prodrugs of fused-bicyclic c5ar antagonists |
| US20190328721A1 (en) | 2018-04-25 | 2019-10-31 | Korea Institute Of Science And Technology | Method of activating dendritic cells |
| CN110200972A (zh) | 2019-05-10 | 2019-09-06 | 南京市儿童医院 | Kd025在制备防治慢性肾纤维化的药物中的用途 |
| WO2021016256A2 (en) | 2019-07-22 | 2021-01-28 | Angion Biomedica Corp. | Ethynylheterocycles as rho-associated coiled-coil kinase (rock) inhibitors |
| CN116209658A (zh) | 2020-07-21 | 2023-06-02 | 安吉昂生物医药公司 | Rho相关卷曲螺旋激酶的抑制剂 |
-
2018
- 2018-08-31 US US16/643,805 patent/US11542256B2/en active Active
- 2018-08-31 CN CN201880056952.1A patent/CN111406051A/zh active Pending
- 2018-08-31 AU AU2018326785A patent/AU2018326785B2/en not_active Ceased
- 2018-08-31 JP JP2020512687A patent/JP2020532551A/ja active Pending
- 2018-08-31 CA CA3073956A patent/CA3073956A1/en active Pending
- 2018-08-31 WO PCT/US2018/049225 patent/WO2019046795A1/en not_active Ceased
- 2018-08-31 EP EP18851935.9A patent/EP3676262A4/en not_active Withdrawn
-
2020
- 2020-02-27 IL IL272939A patent/IL272939A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20200231576A1 (en) | 2020-07-23 |
| AU2018326785B2 (en) | 2023-03-02 |
| WO2019046795A1 (en) | 2019-03-07 |
| US11542256B2 (en) | 2023-01-03 |
| CA3073956A1 (en) | 2019-03-07 |
| EP3676262A4 (en) | 2021-03-31 |
| EP3676262A1 (en) | 2020-07-08 |
| AU2018326785A1 (en) | 2020-04-09 |
| CN111406051A (zh) | 2020-07-10 |
| JP2020532551A (ja) | 2020-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279258B (en) | tyrosine kinase inhibitors | |
| IL268614A (en) | Aminotriazolopyridines as kinase inhibitors | |
| IL274207B (en) | Aminoimidazopyridazines as kinase inhibitors | |
| IL276269A (en) | Aminopyrrolotriazines as kinase inhibitors | |
| EP3131900A4 (en) | Heterocyclic kinase inhibitors | |
| EP3676262A4 (en) | VINYLHETEROCYCLENE AS RHO-ASSOCIATED COILED COIL KINASE (ROCK) INHIBITORS | |
| EP3177295A4 (en) | Uses of salt-inducible kinase (sik) inhibitors | |
| IL289993A (en) | Ethynyl-heterocycles as rho-bound (rock) roller-bound kinase inhibitors | |
| IL257391B (en) | The heteroaryl compounds as mer kinase inhibitors | |
| ZA201703046B (en) | Component for rock breaking system | |
| IL282941B1 (en) | Rock kinase inhibitors | |
| IL252986B (en) | 5,3-diaminopyrazole kinase inhibitors | |
| HK40034167A (en) | Vinylheterocycles as rho-associated coiled-coil kinase (rock) inhibitors | |
| PL3632912T3 (pl) | Pochodne pirydochinazoliny użyteczne jako inhibitory kinaz białkowych | |
| HK40004305A (en) | Kinase inhibitors | |
| AU2017904208A0 (en) | Novel kinase inhibitors i | |
| GB201519381D0 (en) | Kinase inhibitors | |
| GB201519382D0 (en) | Kinase inhibitors | |
| GB201614783D0 (en) | Kinases inhibitors | |
| AU2015903106A0 (en) | Novel kinase inhibitors ii | |
| AU2015904223A0 (en) | Novel kinase inhibitors i |